Search
Total Count 21

SPIMACO - Analyst Estimates

Saudi pharmaceuticals sector seen to grow: Al Rajhi Capital

ِArgaam 09/09/2024

United Securities assigns rating, TP for SPIMACO

Argaam 21/08/2024

What analysts expect from SPIMACO Q2 2024 results?

Argaam Special 28/07/2024

United Securities issues Q2 earnings estimates

Argaam 16/07/2024

SPIMACO net profit expected to rise in Q1 2024

Argaam Special 08/05/2024

Al Rajhi Capital issues Q1 profit forecasts for TASI-listed firms

Argaam 06/04/2024

SPIMACO losses likely to shrink in Q4 2023

Argaam Special 20/02/2024

Al Rajhi Capital issues Q4 2023 earnings forecasts

Argaam Special 08/01/2024

United Securities previews Q4 2023 earnings for Saudi firms

Argaam Special 07/01/2024

Al Rajhi Capital says Saudi pharmaceuticals sector poised for growth; sets recommendations, TP

Argaam 23/11/2023

Al Rajhi Capital issues Q3 profit forecasts for Saudi-listed companies

Argaam Special 05/10/2023

Al Rajhi Capital issues Q2 earnings estimates

ِArgaam 10/07/2023

Al Rajhi Capital begins coverage of Saudi pharma sector, assigns ratings

Argaam 05/07/2023

SPIMACO’s Q3 profit expected to jump 35%

Argaam Special 28/10/2018

Osool & Bakheet issues Q3 forecasts; SABIC seen up 4%

Argaam 08/10/2018

SPIMACO’s net profit likely to rise 7% in Q2

Argaam Special 25/07/2018

Osool & Bakheet issues Q1 forecasts; SABIC seen down 3%

Argaam 08/04/2018

Osool & Bakheet issues Q4 estimates; SABIC seen 20% up

Argaam 06/01/2018

SPIMACO’s Q2 profit said to rise 3% YoY

Argaam Special 25/07/2017

HSBC issues Q2 earnings forecasts; Al Rajhi Bank said to rise 10%

Argaam 12/07/2017

Hermes Capital issues Q2 estimates for Saudi firms

Argaam 12/07/2017